MedPath

ABO-Incompatible Kidney Transplants Between Robot-Assisted vs. Open Surgery

Completed
Conditions
Kidney Transplantation
Interventions
Procedure: robot-assisted kidney transplantation
Registration Number
NCT06287008
Lead Sponsor
Asan Medical Center
Brief Summary

While robot-assisted kidney transplantation (RAKT) offers potential benefits such as minimal postoperative pain, better cosmesis, fewer wound infections, and shorter hospital stay, its efficacy in ABO-incompatible (ABO-i) KT compared to open KT (OKT) remains understudied. This study aims to compare ABO-i KT outcomes between RAKT and OKT.

The study utilized data from 29 ABO-i RAKT and 210 ABO-i OKT cases performed at Asan Medical Center from October 2020 to February 2023. Univariate and multivariate analyses were performed to evaluate factors associated with a composite of biopsy-proven acute rejection (BPAR), de novo donor-specific antibodies (DSA), and overall graft failure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
239
Inclusion Criteria
  • Patient eligible for living donor ABO incompatible kidney transplantation
  • Presenting an IsoAgglutinin immunoglobulin G titer (anti-A-B) between 1/8 and 1/128 before operation
  • Patient older than 18 years and young than 80 years
  • Patient able to sign an informed consent form
Exclusion Criteria
  • Patient with comorbidities or hypersensitivity that prevent desensitization protocols
  • Women who are pregnant, or who may become pregnant or breastfeeding women
  • Subjects under legal protection
  • Subjects participating in another interventional research protocol or in an exclusion period from another interventional research protocolPatient affiliated with a social security scheme

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
RAKTrobot-assisted kidney transplantationpatients who underwent "robot-assisted kidney transplantation"
Primary Outcome Measures
NameTimeMethod
renal function1 year post-operative

renal function measured in terms of eGFR (Estimated Glomerular Filtration Rate)

Graft survival1 year post-operative

allograft (kidney) survival

Secondary Outcome Measures
NameTimeMethod
. A composite of biopsy-proven acute rejection, graft failure, and the development of de novo donor-specific antibodies1 year post-operative

. A composite of biopsy-proven acute rejection, graft failure, and the development of de novo donor-specific antibodies

Trial Locations

Locations (1)

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath